Based on what we know today, what should be the foundational therapy for heart failure patients? Summary and Conclusion.

Event : HFA Discoveries 2020

• Session : Reversing cardiac remodelling and improving outcomes in heart failure: what are our first-choice treatments?
• Speaker : CS Lam (Singapore,SG)

• Sponsorered by Novartis Pharma AG

Discussion.

Event : ESC Congress 2020

• Session : Changing the outlook for a chronic heart failure patient: Optimising RAASi treatment through long-term potassium control
• Speaker : P Van Der Meer (Groningen,NL), CS Lam (Singapore,SG), P Ponikowski (Wroclaw,PL), J Butler (Atlanta,US)

• Organised by PACE-CME, supported by Vifor Pharma Group in the form of an educational grant

Experts on the Spot: Cardiac remodelling and outcomes.

Event : HFA Discoveries 2020

• Session : Experts on the Spot: Cardiac remodelling and outcomes
• Speaker : CS Lam (Singapore,SG), P Seferovic (Belgrade,RS), W Mullens (Genk,BE), M Guazzi (San Donato Milanese,IT)

• Sponsored by Novartis Pharma AG

Heart Failure, a multimorbid syndrome: The increasing challenge to manage.

Event : ESC Congress 2020

• Session : Changing the outlook for a chronic heart failure patient: Optimising RAASi treatment through long-term potassium control
• Speaker : CS Lam (Singapore,SG)

• Organised by PACE-CME, supported by Vifor Pharma Group in the form of an educational grant

HFrEF and HFpEF.

Event : ESC Congress 2020

• Session : The EHJ’s Year in Cardiology: Interventional Cardiology and Heart Failure
• Speaker : CS Lam (Singapore,SG)

Implementing Heart Failure treatments: when is the right time?

Event : ESC Congress 2020

• Session : Making essential treatment choices in heart failure
• Speaker : CS Lam (Singapore,SG)

• Sponsored by Novartis Pharma AG

Insights from Asian Heart Failure and ATTRACT.

Event : ESC Congress 2020

• Session : Ethnic Differences in Cardiovascular Health
• Speaker : CS Lam (Singapore,SG)

• ESC Asia track with the Asian Pacific Society of Cardiology (APSC)

Introduction

Event : HFA Discoveries 2020

• Session : Reversing cardiac remodelling and improving outcomes in heart failure: what are our first-choice treatments?
• Speaker : CS Lam (Singapore,SG), P Seferovic (Belgrade,RS)

• Sponsorered by Novartis Pharma AG

Introduction.

Event : ESC Congress 2020

• Session : Making essential treatment choices for heart failure patients: Experts on the spot
• Speaker : CS Lam (Singapore,SG)

• Sponsored by Novartis Pharma AG

Making essential treatment choices in heart failure - Sponsored by Novartis Pharma AG.

Event : ESC Congress 2020

• Session : Making essential treatment choices in heart failure
• Speaker : A Coats (Warwickshire,GB), M Senni (Bergamo,IT), J Januzzi (Boston,US), CS Lam (Singapore,SG)

• Sponsored by Novartis Pharma AG

New drugs on the horizon: sGC stimulators, myosin activators.

Event : ESC Congress 2020

• Session : Pharmacological Treatment of Chronic Heart Failure
• Speaker : CS Lam (Singapore,SG)

Panel discussion and live Q&A.

Event : ESC Congress 2020

• Session : Therapeutic advances in HFrEF patients who have had a previous worsening HF event
• Speaker : CS Lam (Singapore,SG), B Pieske (Berlin,DE), J Ezekowitz (Edmonton,CA), J Butler (Atlanta,US)

• Sponsored by Bayer AG

Reversing cardiac remodelling and improving outcomes in heart failure: what are our first-choice treatments?

Event : HFA Discoveries 2020

• Session : Reversing cardiac remodelling and improving outcomes in heart failure: what are our first-choice treatments?
• Speaker : CS Lam (Singapore,SG), P Seferovic (Belgrade,RS), W Mullens (Genk,BE), M Guazzi (San Donato Milanese,IT)

• Sponsorered by Novartis Pharma AG

SGLT2 inhibition: Making waves in the heart failure landscape.

Event : HFA Discoveries 2020

• Session : SGLT2 inhibition: Making waves in the heart failure landscape
• Speaker : CS Lam (Singapore,SG), J Butler (Atlanta,US), M Petrie (Glasgow,GB), GMC Rosano (London,GB)

• Organised by CHANGE IME in partnership with Leicester Diabetes Centre

Summary and conclusion.

Event : ESC Congress 2020

• Session : Making essential treatment choices for heart failure patients: Experts on the spot
• Speaker : CS Lam (Singapore,SG)

• Sponsored by Novartis Pharma AG

Summary and conclusion.

Event : ESC Congress 2020

• Session : Making essential treatment choices in heart failure
• Speaker : CS Lam (Singapore,SG)

• Sponsored by Novartis Pharma AG

Welcome and introductions.

Event : ESC Congress 2020

• Session : Therapeutic advances in HFrEF patients who have had a previous worsening HF event
• Speaker : CS Lam (Singapore,SG)

• Sponsored by Bayer AG

ASIAN HF and ATTRACT studies: the strength of an Asian collaboration.

Event : ESC Congress 2019

• Session : Why should registry data impact clinical practice?
• Speaker : CS Lam (Singapore,SG)

• Joint with the Asian Pacific Society of Cardiology

ASIAN-HF and ATTRACT: a purpose built Asian Registry for Chronic Heart Failure.

Event : ESC Asia 2019

• Session : Regional Registries and Trials
• Speaker : CS Lam (Singapore,SG)

Cardiovascular disease in Asia: what place for women?

Event : ESC Congress 2019

• Session : Cardiovascular disease and women: global threat or macro-opportunity
• Speaker : CS Lam (Singapore,SG)

• Promoted by Women in ESC

Case 3: the patient with HFpEF and atrial fibrillation

Event : ESC Congress 2019

• Session : Meet the Experts - Heart failure drug therapy in patients with co-morbidities
• Speaker : CS Lam (Singapore,SG)

Clinical phenotype of HFpEF: the same around the world?

Event : ESC Congress 2019

• Session : Expert Advice - Focus on heart failure with preserved ejection fraction (HFpEF)
• Speaker : CS Lam (Singapore,SG)

Conclusion

Event : ESC Congress 2019

• Session : The heart failure challenge: how well do you know HFpEF?
• Speaker : CS Lam (Singapore,SG)

• Organised by Medscape Education, supported with an independent grant from Novartis Pharma AG

Conclusion and final comments

Event : Heart Failure 2019

• Session : Meet the experts on getting to grips with HFpEF
• Speaker : CS Lam (Singapore,SG)

• Organised by Medscape Education, supported with an educational grant from Novartis

Data from clinical trials.

Event : Heart Failure 2019

• Session : HFmEF: clinical and therapeutic dilemmas
• Speaker : CS Lam (Singapore,SG)

Discussions, questions and answers

Event : ESC Congress 2019

• Session : Treating patients with HFpEF: what progress are we making?
• Speaker : CS Lam (Singapore,SG), JJV McMurray (Glasgow,GB), S Solomon (Boston,US)

• Sponsored by Novartis Pharma AG

Epidemiology of heart failure: incidence, prevalence, and risk factors from a systematic review

Event : Heart Failure 2019

• Session : Chronic Heart Failure – Epidemiology, Prognosis, Outcome
• Speaker : CS Lam (Singapore,SG)

Experts debate - Challenges faced in diagnosing and managing HFpEF.

Event : Heart Failure 2019

• Session : Challenges faced in diagnosing and managing HFpEF
• Speaker : CS Lam (Singapore,SG), JJV McMurray (Glasgow,GB), B Pieske (Berlin,DE), L Lund (Stockholm,SE), A Voors (Groningen,NL)

• Organised by Medscape Education, supported with an educational grant from Novartis

Future Direction for Heart Failure with Preserved Ejection Fraction

Event : ESC Asia 2019

• Session : All I Should Know about Heart Failure with Preserved Ejection Fraction
• Speaker : CS Lam (Singapore,SG)

Heart failure and cardiomyopathies.

Event : ESC Congress 2019

• Session : ESC Congress Highlights
• Speaker : CS Lam (Singapore,SG)

HFpEF past, present and future

Event : Heart Failure 2019

• Session : Meet the experts on getting to grips with HFpEF
• Speaker : CS Lam (Singapore,SG)

• Organised by Medscape Education, supported with an educational grant from Novartis

How well do you know HFpEF? - Questions and panel discussion

Event : ESC Congress 2019

• Session : The heart failure challenge: how well do you know HFpEF?
• Speaker : CS Lam (Singapore,SG)

• Organised by Medscape Education, supported with an independent grant from Novartis Pharma AG

Imaging.

Event : Heart Failure 2019

• Session : The year's best papers on heart failure
• Speaker : CS Lam (Singapore,SG)

Joining the pieces: the heart-kidney connection.

Event : Heart Failure 2019

• Session : Solving the puzzle of heart failure, diabetic kidney disease and risk of stroke: let’s fit the pieces together
• Speaker : CS Lam (Singapore,SG)

• Sponsored by Bayer AG

Key learnings and close

Event : ESC Congress 2019

• Session : Treating patients with HFpEF: what progress are we making?
• Speaker : CS Lam (Singapore,SG)

• Sponsored by Novartis Pharma AG

Panel discussion

Event : Heart Failure 2019

• Session : Meet the experts on getting to grips with HFpEF
• Speaker : CS Lam (Singapore,SG)

• Organised by Medscape Education, supported with an educational grant from Novartis

Q&A and closing - Solving the puzzle of heart failure, diabetic kidney disease and risk of stroke: let’s fit the pieces together.

Event : Heart Failure 2019

• Session : Solving the puzzle of heart failure, diabetic kidney disease and risk of stroke: let’s fit the pieces together
• Speaker : M Cowie (London,GB), K Branch (Seattle,US), H Bonnemeier (Kiel,DE), CS Lam (Singapore,SG)

• Sponsored by Bayer AG

Quiz: what do you know about HFpEF?

Event : ESC Congress 2019

• Session : The heart failure challenge: how well do you know HFpEF?
• Speaker : CS Lam (Singapore,SG)

• Organised by Medscape Education, supported with an independent grant from Novartis Pharma AG

Real world practices and outcomes in the management of heart failure patients with T2DM.

Event : Heart Failure 2019

• Session : Heart Failure, diabetes & SGLT2 inhibition: time to change practice?
• Speaker : CS Lam (Singapore,SG)

• Organised by PACE-CME, Physicians' Academy for Cardiovascular Education, supported with an educational grant from Boehringer Ingelheim

Welcome and introduction

Event : ESC Congress 2019

• Session : Treating patients with HFpEF: what progress are we making?
• Speaker : CS Lam (Singapore,SG)

• Sponsored by Novartis Pharma AG

Welcome and introduction

Event : ESC Congress 2019

• Session : The heart failure challenge: how well do you know HFpEF?
• Speaker : CS Lam (Singapore,SG)

• Organised by Medscape Education, supported with an independent grant from Novartis Pharma AG

Case 1 - Is HFpEF real?

Event : ESC Congress 2018

• Session : Therapeutic dilemmas in heart failure : debate of the experts
• Speaker : M Jessup (Hingham,US), CS Lam (Singapore,SG), S Solomon (Boston,US)

• Organised by Medscape Education, supported with an educational grant from Novartis

Case 2: My HF patient post-hospitalization is easy to manage!

Event : Heart Failure 2018

• Session : Heart failure case debates with the experts
• Speaker : CS Lam (Singapore,SG), J Cleland (Glasgow,GB)

• Organised by Medscape Education, supported with an educational grant by Novartis

Diagnosing HFpEF during atrial fibrillation

Event : Heart Failure 2018

• Session : Atrial fibrillation and HFpEF - Just twins?
• Speaker : CS Lam (Singapore,SG)

Dilemmas in heart failure management: what do the experts say?

Event : ESC Congress 2018

• Session : Dilemmas in heart failure management: what do the experts say?
• Speaker : CS Lam (Singapore,SG), B Pieske (Berlin,DE), S Solomon (Boston,US), F Ruschitzka (Zurich,CH), M Jessup (Hingham,US)

• Organised by Medscape Education, supported with an educational grant by Novartis

Examining heart failure cases with the experts: challenges faced.

Event : Heart Failure 2018

• Session : Examining heart failure cases with the experts: challenges faced
• Speaker : CS Lam (Singapore,SG), M Packer (Dallas,US), J Cleland (Glasgow,GB)

• Sponsored by Novartis

HFpEF: from understanding the physiology to development of new treatments.

Event : Heart Failure 2018

• Session : Novel concepts and treatments of comorbidities in heart failure with preserved ejection fraction
• Speaker : CS Lam (Singapore,SG)

• Organised by PACE and UMCG, supported with educational grants by Novartis and Novo Nordisk

Iron deficiency: an important comorbidity - Discussion and questions.

Event : Heart Failure 2018

• Session : Iron deficiency: an important comorbidity
• Speaker : S Anker (Berlin,DE), P Van Der Meer (Groningen,NL), CS Lam (Singapore,SG), EA Jankowska (Wroclaw,PL)

• Sponsored by Vifor Pharma

Managing iron deficiency: a practical approach.

Event : Heart Failure 2018

• Session : Iron deficiency: an important comorbidity
• Speaker : CS Lam (Singapore,SG)

• Sponsored by Vifor Pharma

Medical therapy

Event : Heart Failure 2018

• Session : HFpEF - The new HFA consensus
• Speaker : CS Lam (Singapore,SG)

New diagnostic algorithms in HFpEF

Event : ESC Congress 2018

• Session : Expert Advice - Diagnosis and treatment of heart failure with preserved ejection fraction (HFpEF)
• Speaker : CS Lam (Singapore,SG)

PROMIS-HFpEF - Microvascular dysfunction in heart failure with preserved ejection fraction (HFpEF): Evidence from the prospective multicenter PRevalence Of Microvascular dySfunction in HFpEF

Event : ESC Congress 2018

• Session : Late Breaking Science in Heart Failure
• Speaker : CS Lam (Singapore,SG)

Role of biomarkers in CVD intensive preventive therapy among T2DM - current guidelines and future perspectives.

Event : Heart Failure 2018

• Session : Biomarker targeted approach in preventing heart failure among patients with diabetes
• Speaker : CS Lam (Singapore,SG)

• Sponsored by Roche

Will this change my clinical practice?

Event : Heart Failure 2018

• Session : Interpretation of biomarkers in chronic heart failure – Easier said than done
• Speaker : CS Lam (Singapore,SG)

Your questions on dilemmas in the treatment of heart failure answered.

Event : Heart Failure 2018

• Session : Your questions on dilemmas in the treatment of heart failure answered
• Speaker : JJV McMurray (Glasgow,GB), CS Lam (Singapore,SG)

• Sponsored by Novartis

Burden and impact of iron deficiency in heart failure.

Event : Heart Failure 2017

• Session : Iron deficiency in patients with heart failure: time for action
• Speaker : CS Lam (Singapore,SG)

• Sponsored by Vifor Pharma

Conclusion and take-home messages

Event : Heart Failure 2017

• Session : Guidelines in Daily Practice III: pharmacological management based on LVEF
• Speaker : CS Lam (Singapore,SG)

Enabling and optimizing RAASi therapy in cardio-renal patients by controlling potassium levels.

Event : Heart Failure 2017

• Session : Enabling and optimizing Renin-Angiotensin-Aldosterone-System inhibitors (RAASi) therapy in cardio-renal patients by controlling potassium levels
• Speaker : M Boehm (Homburg,DE), CS Lam (Singapore,SG)

• Sponsored by Vifor Pharma/Vifor Fresenius Medical Care Renal Pharma

Heart failure with mid-range ejection fraction - Conclusion and take home message.

Event : ESC Congress 2017

• Session : Heart failure with mid-range ejection fraction - What does it mean for clinical practice?
• Speaker : CS Lam (Singapore,SG)

Should iron be at the heart of concerns?

Event : ESC Congress 2017

• Session : Hyperkalaemia and iron deficiency: how too much or too little may affect the heart
• Speaker : CS Lam (Singapore,SG)

• Sponsored by Vifor Pharma

Treatment.

Event : Heart Failure 2017

• Session : A practical guide: how to manage heart failure with mid-range ejection fraction (HFmrEF)?
• Speaker : CS Lam (Singapore,SG)

Are patients missing out? Will new therapy options lead to better heart failure management?

Event : Heart Failure 2016

• Session : Hyperkalaemia: are your patients missing out?
• Speaker : CS Lam (Singapore,SG)

• Sponsored by Vifor Pharma

Ethnic and regional variation in diabetes among Asian patients with heart failure

Event : ESC Congress 2016

• Session : Fighting againts diabetes epidemic
• Speaker : CS Lam (Singapore,SG)

Macrovascular endothelial dysfunction.

Event : ESC Congress 2016

• Session : Heart failure with preserved ejection fraction
• Speaker : CS Lam (Singapore,SG)

Panel discussion.

Event : Heart Failure 2016

• Session : Iron deficiency in heart failure. Guidelines: implementation in clinical practice
• Speaker : CS Lam (Singapore,SG)

• Sponsored by Vifor Pharma

Risk factor differences by geography, income level and ethnicity among patients with heart failure from eleven asian regions (the ASIAN-HF registry)

Event : Heart Failure 2016

• Session : Clinical Forum - Mon. 23 May 08:30 - Tues. 24 May 12:30
• Speaker : CS Lam (Singapore,SG)

Welcome and introduction.

Event : Heart Failure 2016

• Session : Hyperkalaemia: are your patients missing out?
• Speaker : CS Lam (Singapore,SG), B Pitt (Ann Arbor,US)

• Sponsored by Vifor Pharma

Harnessing cyclic GMP signaling for cardiovascular protection - Take home message.

Event : ESC Congress 2015

• Session : Harnessing cyclic GMP signalling for cardiovascular protection
• Speaker : CS Lam (Singapore,SG)

Implication and perspectives.

Event : ESC Congress 2015

• Session : Sleep disordered breathing in Heart Failure (HF), SERVE HF results and beyond
• Speaker : CS Lam (Singapore,SG)

• Sponsored by ResMed

Panel discussion – Sleep disordered breathing in Heart Failure (HF), SERVE HF results and beyond.

Event : ESC Congress 2015

• Session : Sleep disordered breathing in Heart Failure (HF), SERVE HF results and beyond
• Speaker : M Cowie (London,GB), K Wegscheider (Hamburg,DE), H Woehrle (Ulm,DE), CS Lam (Singapore,SG), F Ruschitzka (Zurich,CH), M Metra (Brescia,IT)

• Sponsored by ResMed

Pulmonary hypertension.

Event : Heart Failure 2015

• Session : Heart failure with preserved ejection fraction: what´s the key mechanism?
• Speaker : CS Lam (Singapore,SG)

The unique risk intersection of heart failure and diabetes: lessons learned from real world evidence.

Event : Heart Failure 2015

• Session : What's hot in heart failure: defining unmet medical needs and innovative targets for therapy
• Speaker : CS Lam (Singapore,SG)

• Sponsored by Bayer Healthcare

Does it exist?

Event : ESC Congress 2014

• Session : Challenges in heart failure with preserved ejection fraction
• Speaker : CS Lam (Singapore,SG)

Iron deficiency: a common neglected burden in HF.

Event : ESC Congress 2014

• Session : Iron deficiency in heart failure – The relevance for the patient
• Speaker : CS Lam (Singapore,SG)

• Sponsored by Vifor Pharma

What should cardiologists know about sleep disordered breathing & heart failure in 2014?

Event : ESC Congress 2014

• Session : Sleep disordered breathing in heart failure; time for cardiologists to take control
• Speaker : CS Lam (Singapore,SG)

• Sponsored by ResMed